Cellcolabs
AI-powered platform for personalized cell therapy development and manufacturing.
About
Cellcolabs produces GMP-certified mesenchymal stem cells (MSCs) in Sweden, supporting clinical research and global collaborations. They offer bone-marrow-derived MSCs that are cryopreserved, genetically stable, and antibiotic-free, manufactured under the oversight of the Swedish Medical Products Agency. Cellcolabs aims to make high-quality stem cells available at an industrial scale for advanced cell therapies. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Cellcolabs do?
Cellcolabs is a Biotech company that offers Platform. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in Tel Aviv, Israel and was founded in 2021. Public records show about 79 people and $16M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Cellcolabs raised?
Cellcolabs has raised a total of $16M in funding.
Where is Cellcolabs headquartered?
Cellcolabs is headquartered in Tel Aviv, Israel.
When was Cellcolabs founded?
Cellcolabs was founded in 2021.
What industry does Cellcolabs operate in?
Cellcolabs operates in Biotech, MedTech, HealthTech, Drug Discovery, AI-Driven Protein Design.
How many employees does Cellcolabs have?
Cellcolabs has approximately 79 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.